NDAORALTABLETPriority Review
Approved
Sep 1993
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Priority Review
FLUMADINE (rimantadine hydrochloride) by PharmaIN is mechanism of action the mechanism of action of rimantadine is not fully understood. First approved in 1993.
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Flumadine (rimantadine hydrochloride) is an oral antiviral tablet approved in 1993 for the treatment and prophylaxis of influenza A virus infection. The drug works by inhibiting viral uncoating early in the replicative cycle, targeting the M2 protein encoded by the influenza A virion. It is administered orally and represents one of the earliest classes of neuraminidase inhibitors.
LOE Approaching
With LOE approaching after 30+ years on market, the commercial team is likely focused on managed decline and transition planning rather than growth initiatives.
Mechanism of Action
Mechanism of Action The mechanism of action of rimantadine is not fully understood. Rimantadine appears to exert its inhibitory effect early in the viral replicative cycle, possibly inhibiting the uncoating of the virus. Genetic studies suggest that a virus protein specified by the virion M 2 gene…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Flumadine offers limited growth upside but provides stability in a mature, well-understood franchise with predictable demand during flu season. Career development on this product is best suited for professionals interested in legacy brand management, managed markets, or transition planning rather than innovation-focused roles.
Brand Manager
Worked on FLUMADINE at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.